Electromed, Inc.
About Electromed, Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $64.0M
- Net income
- $7.5M
- Total assets
- $53.8M
- Market cap
- $312.1M
- Gross margin
- 78.1%
- Operating margin
- 15.1%
- Net margin
- 11.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $64.0M
- Cost of revenue
- $14.0M
- Gross profit
- $50.0M
- Operating expenses
- $40.3M
- Operating income
- $9.7M
- Income tax
- $2.7M
- Net income
- $7.5M
- EPS (basic)
- $0.89
- EPS (diluted)
- $0.85
Balance sheet
- Total assets
- $53.8M
- Current assets
- $45.1M
- Total liabilities
- $10.6M
- Current liabilities
- $10.5M
- Shareholders’ equity
- $43.2M
Cash flow
- Operating cash flow
- $11.4M
- Investing cash flow
- -$306.0K
- Financing cash flow
- -$11.9M
- Net cash flow
- -$793.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $312.1M
- P/E ratio
- 43.6
- EPS (diluted)
- $0.85
- Shares outstanding
- 8.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 13, 2010
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $7.5M in FY2025.
- Revenue grew 79% from FY2021 to FY2025.
- Gross margin of 78.1%, net margin 11.8%.
- Trading 6% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 43.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Electromed, Inc..
Write a review
News about Electromed, Inc.
News & sentiment via Polygon.io
